Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acumen Pharmaceuticals
Acumen Pharmaceuticals
(ABOS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Histone-arginine methyltransferase carm1
pancreatic neoplasms
,
stomach neoplasms
,
neuroendocrine tumors
,
intestinal neoplasms
Surlorian
type 1 diabetes mellitus
,
leukemia
,
lung neoplasms
,
brain neoplasms
,
neoplasms
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
lymphoma
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
preleukemia
,
syndrome
,
tuberculosis
,
pulmonary tuberculosis
,
colorectal neoplasms
,
sinusitis
,
nasal polyps
,
polyps
,
rhinosinusitis
,
acne vulgaris
,
breast neoplasms
,
crohn disease
,
prostatic neoplasms
,
diabetes mellitus
,
type 2 diabetes mellitus
,
eosinophilic esophagitis
,
esophagitis
,
liver diseases
,
liver transplantation
,
immunosuppression therapy
,
chronic obstructive pulmonary disease
,
lung diseases
,
asthma
SABIRNETUG
alzheimer disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use